GESTIÓN EN SALUD PÚBLICA: Watch out for hand sanitizers packaged in food and drink containers | First rapid COVID-19 test where results can be read directly from testing card

miércoles, 2 de septiembre de 2020

Watch out for hand sanitizers packaged in food and drink containers | First rapid COVID-19 test where results can be read directly from testing card

FDA Medical Countermeasures Initiative Update

FDA is taking an “all-hands-on-deck” approach to tackling this pandemic, and colleagues across the entire organization work tirelessly for the American people

Events

Today! September 2, 2020: Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests - FDA will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SAR-CoV-2, 12:15 p.m. - 1:15 p.m. ET. FDA will host additional town halls in this series on Wednesdays in September. To ensure you are connected, please dial-in at 12:00 p.m.
New! September 10, 2020: FDA Grand Rounds webcast: Advancing the Science of Real-World Data to Address the COVID-19 Pandemic, presented Amy P. Abernethy, MD, PhD, FDA Principal Deputy Commissioner and Acting Chief Information Officer, 12:00 - 1:00 p.m. ET, CE credit available
September 15, 2020: Save the date for the next event in FDA's webinar series to share information and answer your questions on respirators and other personal protective equipment (PPE). Printable slides and transcripts from previous events in this series are available.
September 17-18, 2020: Considerations for the Use of Real-World Evidence to Assess the Effectiveness of Preventive Vaccines - virtual workshop - agenda (PDF)
October 2, 2020: Vaccines and Related Biological Products Advisory Committee (webcast) - The committee will recommend strains for the 2021 Southern Hemisphere influenza vaccines licensed in the U.S., which is part of FDA’s year-round efforts to flight flu, along with other public health partners like CDC and NIH.
New! October 22, 2020: Vaccines and Related Biological Products Advisory Committee (webcast) - The committee will discuss, in general, the development, authorization, and/or licensure of vaccines to prevent COVID-19. No specific application will be discussed at this meeting.

Information for industry

The FDA is committed to providing timely recommendations, regulatory information, guidance, and technical assistance necessary to support rapid COVID-19 response efforts. FDA has issued more than 50 COVID-19-related guidances to date.